Drugs For Diabetes
- All
- News
- Videos
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
AI Revolutionising Fight Against Cancer And Diabetes
AI in drug discovery Artificial intelligence is rapidly transforming the way new drugs and therapeutic targets are discovered in cancer immunology.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Ozempic: How The Venom Of A Lizard Paved Way For Popular Diabetes Drug
These medications, now widely used for treating diabetes and obesity, owe their existence to a key component of the lizard's venom.
-
Some Diabetes Patients Achieve Remission With GLP-1 Drugs: Italian Study
An Italian study shows that using GLP-1 receptor agonists can lead to remission in up to 18% of cases, especially when used early and in patients with fewer complications.
-
Ozempic Is Here In India But It's Not A Magic Weight Loss Pill, Says Nutritionist
Ozempic arrives in India, but nutritionist Nmami Agarwal encourages reasonable expectations amid the hype.
-
Ozempic Coming Soon To India: 14 Facts About The Diabetes, Weight Loss Drug
Semaglutide (Ozempic), a once-weekly injectable already approved globally, has now been cleared for use in India for type 2 diabetes.
-
Ozempic Cleared For Use In India: Pros, Cons And Expected Price
Ozempic is the trade name for semaglutide, a once-weekly injectable medicine that belongs to the class called GLP-1 receptor agonists. A higher-dose semaglutide better known as Wegovy is licensed for chronic weight management.
-
Lilly's Obesity Pill Will Have Far-Reaching Effect, Doctors Say
Oral versions of popular weight-loss shots are some of the next big things in the obesity market, which Bloomberg Intelligence estimates will reach $100 billion in annual sales by 2030.
-
AI Revolutionising Fight Against Cancer And Diabetes
AI in drug discovery Artificial intelligence is rapidly transforming the way new drugs and therapeutic targets are discovered in cancer immunology.
-
Higher Doses Of Semaglutide Safe, Can Aid In Better Weight Loss For Obese Adults: Study
A study published in The Lancet Diabetes & Endocrinology journal, suggest that a higher dose of semaglutide offers a promising new option for people who have not achieved sufficient weight loss with existing treatments.
-
WHO Adds Key Diabetes, Weight-Loss Drugs To Essential Medicines List
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for type 2 diabetes with obesity or comorbidities.
-
WHO Backs Weight-Loss Drugs To Treat Diabetes, Obesity, Urges Cheap Generics
The World Health Organization recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity globally for the first time on Friday, calling for cheap generic versions to be made available for people in developing countries.
-
Weight Loss Ad Sparks Controversy: "Don't Promote Obesity, It's A lifestyle Disease," Say Experts
Obesity is a common risk factor for several serious health conditions like diabetes, heart disease, hypertension, fatty liver and others.
-
Mounjaro: Everything You Need To Know About This Medication
Read on as we discuss everything you need to know about this medication.
-
Eli Lilly Launches Weight Loss Drug In India: What You Should Know About Mounjaro
Mounjaro for Weight Loss: By influencing multiple body systems simultaneously, tirzepatide offers a powerful approach to managing both diabetes and weight.
-
'Once-A-Week Shot' Weight-Loss Drug Mounjaro Launched In India By Eli Lilly
Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).
-
Biocon Launches Diabetes, Obesity Management Drug In UK
Biotechnology firm Biocon on Friday said it has launched a product for diabetes and obesity management in the UK.
-
Ozempic: How The Venom Of A Lizard Paved Way For Popular Diabetes Drug
These medications, now widely used for treating diabetes and obesity, owe their existence to a key component of the lizard's venom.
